It has been reported that CAFs inhibited the expression of VASH1 by affecting the expression of VEGF and then upregulating the expression of EZH2 in HCC, thereby promoting the proliferation and angiogenesis of human umbilical vein endothelial cells (HUVECs). This evidence concerns the gene VASH1 and hepatocellular carcinoma.